EAM
BDSI

EverPoint Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

EverPoint Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-500,000
Closed -$2.78M – 603
2015
Q3 		$2.78M Hold
500,000
– – 0.07% 298
2015
Q2 		$3.98M Buy
+500,000
New +$4.3M 0.07% 309

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

EverPoint Asset Management's BDSI Position: Q1 2016 in Review

EverPoint Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2016, closing a stake of 435,585 shares — an estimated $2.09M sold.

EverPoint Asset Management first reported a position in BDSI in Q1 2015 and held it in 4 quarters. The position peaked at $18.7M in Q2 2015. 105 funds tracked by Wall St. Rank hold BDSI as of Q1 2016.

  • EverPoint Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2016 after selling out during the quarter.
  • EverPoint Asset Management sold 435,585 BioDelivery Sciences International, Inc. shares in Q1 2016, an estimated $2.09M.
  • EverPoint Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 4 quarters.
  • EverPoint Asset Management's BioDelivery Sciences International, Inc. position peaked at $18.7M in Q2 2015.
  • 105 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2016.

Based on EverPoint Asset Management's 13F filing for Q1 2016, filed 16 May 2016.